S. Zupo et al., Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD, BLOOD, 95(4), 2000, pp. 1199-1206
Previously, we demonstrated that B-chronic lymphocytic leukemia (B-CLL) cel
ls could be divided into 2 groups depending on the expression of CD38 by th
e malignant cells. The 2 groups differed in their signal-transducing capaci
ties initiated by cross-linking of surface IgM;; only in CD38-positive cell
s was an efficient signal delivered, invariably resulting in cell apoptosis
, In this study, we investigated the effect of surface IgD cross-linking in
10 patients with CD38-positive B-CLL. Exposure of the malignant cells to g
oat antihuman delta-chain antibodies (Ga delta-ab) caused [Ca++]i mobilizat
ion and tyrosine kinase phosphorylation in a manner not different from that
observed after goat antihuman mu-chain antibody (Ga mu-ab) treatment in vi
tro. However, Ga delta-ab-treated cells failed to undergo apoptosis and ins
tead displayed prolonged survival in culture and differentiated into plasma
cells when rlL2 was concomitantly present. Cross-linking of surface IgD fa
iled to induce proliferation of the malignant cells in vitro. Moreover, tre
atment with Ga delta-ab did not prevent apoptosis of B-CLL cells induced by
Ga mu-ab. Collectively, these experiments demonstrated that IgM and IgD ex
pressed by the same cell may deliver opposite signals under particular circ
umstances and provide some clues for the understanding of the pathophysiolo
gy of B-CLL.(Blood. 2000;95:1199-1206) (C) 2000 by The American Society of
Hematology.